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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYInduced pluripotent stem cells (iPSCs) acquire embryonic stem cell (ESC)-like epigenetic states, including the X chromosome. Previous
studies reported that human iPSCs retain the inactive X chromosome of parental cells, or acquire two active X chromosomes through
reprogramming. Most studies investigated the X chromosome states in established human iPSC clones after completion of reprogram-
ming. Thus, it is still not fully understood when and how the X chromosome reactivation occurs during reprogramming. Here, we report
a dynamic change in the X chromosome state throughout reprogramming, with an initial robust reactivation of the inactive X chromo-
some followed by an inactivation upon generation of nascent iPSC clones. iPSCs with two active X chromosomes or an eroded X chro-
mosome arise in passaging iPSCs. These data provide important insights into the plasticity of the X chromosome of human female iPSCs
and will be crucial for the future application of such cells in cell therapy and X-linked disease modeling.INTRODUCTION
Expression of a defined set of transcription factors (OCT4,
SOX2, KLF4, and c-MYC) reprograms human somatic cells
to a pluripotent state, generating induced pluripotent stem
cells (iPSCs) (Park et al., 2008b; Takahashi et al., 2007; Yu
et al., 2007). iPSCs are similar to embryonic stem cells
(ESCs) and are capable of indefinite self-renewal and differ-
entiation into cells of all three germ layers. iPSCs alsomain-
tain the genomic composition of parental somatic cells and
thus are considered as autologous cellular resources that are
critical for cell therapy and in vitro disease modeling (Park
et al., 2008a;Wu andHochedlinger, 2011). Detailed genetic
and epigenetic comparisons between iPSCs and ESCs, how-
ever, have shown that they are close but not identical (Chin
et al., 2009). Reprogramming leaves reprogramming-spe-
cific epigenetic marks and produces copy number variation
(Hussein et al., 2011; Lister et al., 2011). In addition,
de novo mutations seem to accompany reprogramming
and cause genetic alterations in iPSCs, although more in-
depth analyses are needed before we can draw definite con-
clusions regarding the genetic changes in reprogramming
(Abyzov et al., 2012; Gore et al., 2011).
Reprogramming affects the X chromosome status in
female cells. During early development, one of the active
X chromosomes in the inner cell mass (ICM) cells of the
blastocyst undergoes random X chromosome inactivation
(XCI) when ICM cells differentiate into epiblast cells
(Mak et al., 2004). Only cells that are committed to devel-
oping as primordial germ cells (PGCs) start to reactivate
the inactive X chromosome duringmigration to the genital896 Stem Cell Reports j Vol. 2 j 896–909 j June 3, 2014 j ª2014 The Authorridge. In contrast, somatic cells maintain the inactive X
chromosome throughout their life (de Napoles et al.,
2007). Murine ESCs derived from ICM cells are considered
to be in a naive state, and there are two active X chromo-
somes in female ESCs (Hanna et al., 2010). The X chromo-
some status in murine female iPSCs is indistinguishable
from that in murine ESCs. Reprogramming activates the
inactive X chromosome to produce iPSCs with two active
X chromosomes (Maherali et al., 2007). Human ESCs are
presumed to be derived from the epiblast cells of the
embryo and have one inactive X chromosome. However,
successful derivation of human ESCs with two active X
chromosomes suggested that human ESCs are counterparts
of ICM cells as well, but are prone to undergo XCI unless
they are maintained in a pristine physiological condition,
including a hypoxic oxygen concentration and no oxida-
tive stress (Diaz Perez et al., 2012; Lengner et al., 2010).
Thus, most human ESCs were reported to carry only one
active X chromosome. In-depth studies on female human
ESCs categorized them into three classes according to their
X chromosome status (Kim et al., 2011; Lessing et al.,
2013). Class I female human ESCs have two active X chro-
mosomes, like murine ESCs, and show neither H3K27me3
nor XIST foci. When differentiated, class I ESCs undergo
random XCI and form H3K27me3 foci and a XIST cloud.
Spontaneous inactivation of one of the two X chromo-
somes in class I ESCs results in the formation of
H3K27me3 and XIST foci, leading to the conversion of
class I to class II cells. Class II ESCs maintain the inactive
X chromosome after differentiation. However, the inactive
X chromosome in class II ESCs is reversible and becomess
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Perez et al., 2012). Continuous long-term passaging of
H3K27me3 foci-positive class II ESCs triggers them to
become H3K27me3 foci-negative class III ESCs. Although
they are negative for H3K27me3 foci and XIST expression,
class III ESCs carry one inactive X chromosome whose sta-
tus seems to be permanent, and do not show H3K27me3
foci upon differentiation (Diaz Perez et al., 2012). As in
the case of human ESCs, female iPSCs seem to have only
one active X chromosome because they retain the inactive
Xchromosome (Tchieu et al., 2010).However, somegroups,
including ours, have found that iPSCs with two active X
chromosomes can be generated via reprogramming (Kim
et al., 2011; Marchetto et al., 2010; Tomoda et al., 2012).
Others found that reprogramming does not reactivate the
inactive X chromosome, and instead the unstable inactive
X chromosome undergoes epigenetic erosion, producing
class III iPSCs (Mekhoubad et al., 2012). The female iPSCs
that have lostXISTexpression seem to be less desirable cells
for cell therapy or disease modeling because XIST loss is
highly correlatedwith upregulation ofX-linked oncogenes,
which leads to a high growth rate and poor differentiation
(Anguera et al., 2012). A recent study showed that high
expression of leukemia inhibitory factor (LIF) facilitates
thederivationof iPSCswith twoactiveXchromosomes (To-
moda et al., 2012). The difference in X chromosome status
in iPSCs among different labs suggests that the X chromo-
some is not in a stable state in current culture conditions.
There are many X-linked diseases in females for which
iPSC-based disease modeling and future cell therapies are
readily applicable. Thus, information regarding X chromo-
some status during reprogramming and in established
iPSCs is critical. Here, we set out to detail the change in
X chromosome status that occurs during human female
somatic cell reprogramming. Remarkably, we found that
the change in the X chromosome is dynamic during re-
programming. Reprogramming at the early stage causes re-
activation of the inactive X chromosome of the parental
fibroblast, which does not seem to be permanent and
rapidly becomes inactivated in the nascent iPSC colonies.
The inactive X chromosome can be reactivated, eroded,
or maintained during early passages in established iPSCs,
producing class I, II, and III iPSCs that have different states
of X chromosome. Our data suggest that the X chromo-
some status is not permanently fixed, but is plastic during
human somatic cell reprogramming.RESULTS
Reprogramming Changes the X Chromosome Status
In order tomonitor changes in the inactive X chromosome
state during female somatic cell reprogramming, we tookSteadvantage of a monoallelic D551-iPSCK1 clone that is
derived from normal female Detroit 551 fibroblasts and
has only one active X chromosome. We monitored the X
chromosome status of the monoallelic D551-iPSCK1 clone
byH3K27me3 staining and by performing a SNP analysis of
X-linked genes (e.g., the TT allele in GRPR; Figure 1A). Dif-
ferentiation in the D551-iPSCK1 cells was induced to pro-
duce dfD551-K1 fibroblast-like cells that maintained the
specificity of X chromosome allelic gene expression, and
expressed only the TT SNP of the GRPR gene. We then re-
programmed dfD551-K1 cells and derived ten clones of
dfD551K1-iPSC lines, and examined the X chromosome
status (Figure 1A; Figure S1A available online; Table 1).
Two clones of dfD551K1-iPSC showed expression of the
TT SNP GRPR of the parental fibroblasts (Tchieu et al.,
2010). We found that six dfD551K1-iPSC clones expressed
both AA and TTalleles ofGRPR thatmay have acquired two
active X chromosomes via X chromosome reactivation
(XCR) during reprogramming (Tomoda et al., 2012). How-
ever, unexpectedly, two clones of dfD551K1-iPSC ex-
pressed GRPR with the AA allele. If the iPSC retains the
inactive X chromosome state or reactivates the inactive X
chromosome, iPSC clones expressing X-linked genes with
the opposite SNP of the parental fibroblasts are not ex-
pected to be produced. We confirmed the X chromosome
status of the dfD551K1-iPSC clones by examining the pres-
ence of H3K27me3 foci and XIST clouds, which are present
inmonoallelic clones and absent in biallelic clones (Figures
1B and 1C). We then compared the transcription of XCI-
related genes and X-linked genes between mono- and bial-
lelic dfD551K1-iPSC clones. iPSC lines without H3K27me3
foci showed lower expression of XCI-related XIST, EZH2,
and RNF12, but showed higher expression of X-linked
MECP2 (methyl CpG-binding protein 2) and HPRT (hypo-
xanthine-guanine phosphoribosyl transferase), represent-
ing the absence of the inactive X chromosome (Figure S1B).
These data suggest that the inactive X chromosome of
fibroblasts may have undergone a reactivation and then a
subsequent inactivation during reprogramming. Similarly,
we differentiated monoallelic Rett syndrome (RTT) iPSC
lines and generated fibroblast-like cells that expressed
only one allele of the X-linked gene MECP2 (dfRTT3-
46m, dfRTT4-24w, and dfRTT5-34m). We generated clones
of iPSCs from these fibroblast-like cells and examined the
allelic expression of MECP2. As with the iPSC clones
derived from dfD551-K1 cells, we found iPSC clones with
the same allelic expression of MECP2 as the parental fibro-
blasts, the opposite SNP, or both (Figures S1C–S1E; Table 1),
further supporting our finding of X chromosome dy-
namics, including reactivation, during reprogramming.
In order to elucidate the dynamics of X chromosome
during reprogramming, we traced the X chromosome
status in cells undergoing reprogramming. Followingm Cell Reports j Vol. 2 j 896–909 j June 3, 2014 j ª2014 The Authors 897
(legend on next page)
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Table 1. Clonal Fibroblast Lines and the iPSC Clonal Lines Derived from Them







D551-iPSCK1 dfD551-K1 GRPR TT/AA at 2,411–2,412 2 6 2
6TG-iPSC3 df6TG-3 GYG2 C/T at 998 2 2 2
GYG2 A/G at 1,127
HAT-iPSC1 dfHAT-1 GYG2 C/T at 998 2 3 1
GYG2 A/G at 1,127
MAOA A/G at 4,100
RTT3-iPSC-46m dfRTT3-46m MECP2 Del G at 705 4 3 2
RTT4-iPSC-24w dfRTT4-24w MECP2 C/T at 916 4 2 5
RTT5-iPSC-34m dfRTT5-34m MECP2 A/G at 1,461 2 4 3
fLNS HPRT+/ fLNS-6TG GYG2 C/T at 998 4 3 2
GYG2 A/G at 1,127
MAOA A/G at 4,100
Fibroblast-like cells were generated from monoallelic iPSCs by differentiation. fLNS-6TG fibroblasts resistant to 6TG or fLNS-HAT fibroblasts resistant to HAT
were selected from LNS fibroblasts with 6TG treatment or HAT medium. Differentiated fibroblasts, fLNS-6TG, and fLNS-HAT have monoallelic expression of
genes on the X chromosome. When induced for reprogramming, iPSC clones with the same allelic expression of X-linked genes of the parental fibroblasts,
iPSC clones with the opposite allele, or both are produced.
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7, 14, and 21 days for analysis in X chromosome state. First,
we examined the change in H3K27me3 foci, which is the
most reliable marker for the presence of an inactive X chro-
mosome (Plath et al., 2003). As reprogramming proceeded,
the percentage of cells with H3K27me3 foci gradually
decreased and became 7% at day 21 (Figures 1D and 1E).
These data further support the notion that reprogramming
reactivates the inactive X chromosome. We also found aFigure 1. Analysis of the X Chromosome Status of Female iPSC Li
(A) SNP analysis of allelic-specific expression of X-linked GRPR gene
entiated fibroblasts (dfD551-K1), and secondary iPSC clones from dfD
were reprogrammed, secondary iPSC clones that express TT SNP (dfD
iPSC21) were generated.
(B) RNA FISH for XIST in secondary iPSC lines at passage 12. Monoal
iPSC21 does not, confirming the X chromosome status. Scale bar, 20
(C) Immunostaining of H3K27me3 and OCT4 in secondary iPSC lin
H3K27me3 foci, representing the presence of inactive X chromosome, w
DAPI. Scale bar, 20 mm.
(D) Immunostaining of H3K27me3 (red) in Detroit 551 fibroblasts u
resents the expression of retrovirus-mediated reprogramming factors,
reprogramming lose H3K27me3 foci. Scale bar, 20 mm.
(E)Quantificationof theH3K27me3 foci+ andH3K27me3 foci cells in (A
(F) Relative expression of total (upper panel) and ectopic (lower pan
(G) Relative mRNA expression of genes involved in XCI and pluripoten
fibroblasts undergoing reprogramming were sorted according to the ex
TRA160, and retroviral GFP. Error bars represent mean ± SEM of three
Stegradual decrease of H3K27me3 foci-positive cells in three
other primary fibroblast cell lines (RTT3, WI38, and
IMR90; Figures S2A–S2C).
Next, we examined whether the expression of genes that
are critical for XCI changes during reprogramming.We iso-
lated total RNA in cells undergoing reprogramming at 10,
14, 21, and 28 days after reprogramming, and analyzed
the expression of XCI-related and pluripotent genes (Fig-
ure S2D). XIST is a noncoding RNA whose expression andnes Derived from Secondary Reprogramming
in iPSC (D551-iPSCK1) derived from Detroit 551 fibroblasts, differ-
551-K1. When monoallelic dfD551-K1 cells having TT SNP in GRPR
551K1-iPSC32), AA SNP (dfD551K1-iPSC22), or TT/AA (dfD551K1-
lelic dfD551-PSC32 shows XIST clouds, whereas biallelic dfD551K1-
mm.
es derived from dfD551-K1 fibroblasts. dfD551K1-iPSC32 shows
hereas dfD551K1-iPSC21 does not. Nuclei were counterstained with
ndergoing reprogramming on the indicated days. GFP (green) rep-
and nuclei were counterstained with DAPI (blue). GFP+ cells under
). Error bars representmean± SEMof three independent experiments.
el) OCT4, SOX2, KLF4, and MYC.
cy during reprogramming. Homogeneous populations of Detroit 551
pression of fibroblast marker CD13, pluripotency markers SSEA4 and
independent experiments.
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Recently, the LIM-domain protein RNF12 was shown to
be a positive transcription activator for XIST (Gontan
et al., 2012; Navarro et al., 2011). The expression of XIST
and RNF12 decreased during reprogramming, consistent
with the decrease in the percentage of cells with
H3K27me3-positive foci, whereas the pluripotency
markers increased (Figure S2D). Previously, we found that
reprogramming is a progressive process that can be defined
by the change in cell-surface markers and the retroviral
gene expression (Chan et al., 2009). Prior to reprogram-
ming, fibroblasts express the cell-surface marker CD13,
which is rapidly repressed by the expression of reprogram-
ming factors marked by the expression of GFP contained in
retroviral vector. The silencing of GFP marks the formation
of bona fide iPSCs that express SSEA4 and TRA160 cell-sur-
face markers (Chan et al., 2009). These cell-surface markers
can be utilized to further dissect and isolate cells in progres-
sive reprogramming stages: CD13+GFP-SSEA4-TRA160,
fibroblasts; CD13-GFP+SSEA4+TRA160, partially reprog-
rammed cells; and CD13-GFP-SSEA4+TRA160+, fully
reprogrammed cells (Chan et al., 2009). Using fluores-
cence-activated cell sorting (FACS), we isolated cells using
a combination of markers and purified total RNA, and
performed a gene-expression analysis (Figure 1F). CD13+
fibroblasts that had strong H3K27me3 foci showed high
expression of XIST and RNF12, which is consistent with
their role in XCI. CD13-GFP+ cells that were isolated at
days 14 and 28 after reprogramming showed high expres-
sion of ectopic reprogramming factors and a dramatic
reduction in expression of XIST and RNF12 (Figures 1F
and 1G).When cells became bona fide iPSCs and expressed
TRA160, the ectopic expression of four reprogramming fac-
tors was dramatically reduced (Figure 1F). These data sug-
gest that the high expression of ectopic reprogramming
factors induces X reactivation during reprogramming.
In order to rule out the possibility that the presence of
contaminating cells with the opposite SNP of genes in
parental fibroblasts is responsible for the formation of sec-
ondary iPSC clones with the opposite SNP, we used female
fibroblasts from Lesch-Nyhan syndrome (LNS) cells with a
mutation inHPRT. LNS fibroblasts display amosaic pattern
of X-linked HPRT expression. Fibroblasts that have mutant
HPRT on an active X chromosome (XaHPRTXiHPRT+), and
therefore lack HPRT activity, are sensitive to hypoxan-
thine-aminopterin-thymidine (HAT) inmedium. However,
they do not metabolize 6-thio-guanine (6TG), whose toxic
metabolites kill cells with an active HPRT, and thus they
can grow in medium with 6TG. In contrast, fibroblasts
with a wild-type HPRT allele on an active X chromosome
(XaHPRT+XiHPRT) are resistant to HAT but sensitive to
6TG (Figure 2A). Using this differential sensitivity to HAT
and 6TG, we isolated two homogeneous cell populations:900 Stem Cell Reports j Vol. 2 j 896–909 j June 3, 2014 j ª2014 The Authorone with 6TG resistance (fLNS-6TG [XaHPRTXiHPRT+])
and onewith HAT resistance (fLNS-HAT [XaHPRT+XiHPRT]).
In order to test the stability of drug selectivity, cells that
were selected with either drug were cultured without the
drug for 2 weeks, and then drug sensitivity was tested.
fLNS-HAT fibroblasts previously selected for HAT resistance
showed no resistance to 6TG, and fLNS-6TG fibroblasts
previously selected for 6TG did not survive in the HAT
condition (Figure S3A). These data suggest that XCI states
in the drug-selected cells were stably maintained. These
two homogeneous populations of cell lines having only
one active X chromosome were reprogrammed. We
examined the X chromosome status of iPSC clones by
testing the drug sensitivity and analyzing SNPs of genes
on the X chromosome (Figure 2A). Like the iPSCs derived
from clonally differentiated dfD551-K1, the iPSC clones
that were generated from fLNS-6TG had different X
chromosome states and drug sensitivities: 6TG-iPSC3,
6TG resistance (XaHPRTXiHPRT+); 6TG-iPSC1, HAT resis-
tance (XaHPRT+XiHPRT); and 6TG-iPSC6, HAT resistance
(XaHPRT+XaHPRT; Figure 2B). In addition to drug resistance,
we performed a SNP analysis in the X-linked GYG2 gene.
Consistent with drug-resistance phenotypes, these iPSC
clones showed allelic specificity (at nucleotide 1,127 of
mRNA) of the GYG2 gene: 6TG-iPSC3, (G) SNP; 6TG-
iPSC1, (A) SNP; and 6TG-iPSC6, (G/A) SNPs (Figure 2B).
The generation of HAT-resistant clones (e.g., 6TG-iPSC1)
from 6TG-selected fibroblasts further supports our finding
that XCR occurs during reprogramming. In order to further
confirm the conversion of the drug sensitivity of iPSCs, we
differentiated 6TG-resistant monoallelic 6TG-iPSC3 and
generated df6TG-3 fibroblast (XaHPRTXiHPRT+). df6TG-3
cells were reprogrammed (Figure 2A). HPRT activity and
SNP were again examined with secondary iPSC clones. As
with the iPSC clones derived from drug-selected primary
fibroblasts, the converted SNP and HPRT activities were
observed in secondary iPSC lines (Figure 2C).When six sec-
ondary iPSC clones from df6TG-3 were treated with either
6TGorHAT, two clones showed resistance only to 6TG. The
other four clones died under the 6TG culture condition, but
survived in the presence of HAT in themedium (Figure 2C).
In addition, SNP of the X-linkedGYG2 gene was examined.
Two of six df6TG3-iPSC clones had the same SNP (at 998 nt
of mRNA) GYG2 (T) as the parental df6TG-3 cells
(XaHPRTXiHPRT+). Out of four df6TG3-iPSC clones that
acquired HAT resistance, two showed monoallelic (C) SNP
in GYG2 (XaHPRT+XiHPRT), and the other two showed
biallelic SNP patterns (XaHPRTXaHPRT+; Figure S3B). The
differential GYG2 SNPs were also confirmed via restric-
tion-enzyme-sensitive digest (Figure 2D). GYG2 SNPs
(either C or T) were differentially cleaved depending on
the XCI status, as shown in Figure 2D, and strongly
correlated with the status of H3K27me3 foci (Figure 2E).s
Figure 2. Formation of Female iPSCs with a Different X Chromosome State Compared with the Parental fLNS-6TG (XaHPRTXiHPRT+)
Fibroblast
(A) Schematic representation of strategy for generating homogeneous fibroblasts from LNS patients with a HPRT mutation. Culture with
6TG or HAT produces two homogeneous populations of fibroblasts with X chromosome in either the (XaHPRTXiHPRT+, fLNS-6TG) or
(XaHPRT+XiHPRT, fLNS-HAT) state.
(B) Generation of HAT-resistant clones from 6TG-selected fLNS-6TG fibroblasts. Allelic-specific expression of GYG2 is shown in the left
column, and resistance to HAT or 6TG is shown by crystal violet staining of iPSC clones after treatment with HAT or 6TG for 10 days.
(C) Generation of HAT-resistant secondary iPSC clones from 6TG-resistant fibroblasts (df6TG-3) of the 6TG-resistant iPSC clone (6TG-
iPSC3). Crystal violet staining of secondary iPSC lines after selection with HAT or 6TG is shown.
(D) Analysis of allele-specific expression of GYG2 in secondary iPSC lines via restriction-enzyme-sensitive SNP. Allele-specific GYG2 SNPs
were amplified by PCR and digested with BstIMutI restriction enzyme.
(E) Representative images of H3K27me3/OCT4 immunostaining with secondary df6TG-iPSC lines. Scale bar, 20 mm.
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tivation of the inactive X chromosome was found in re-
programming fLNS-HAT (XaHPRT+ XiHPRT) and secondary
reprogramming dfHAT-1 (XaHPRT+ XiHPRT). Not onlySteHAT-resistant iPSCs but also 6TG-resistant iPSC clones
were isolated from reprogramming of fLNS-HAT cells and
dfHAT-1 cells (Figure S3C). The allelic specificity of the
X chromosome of dfHAT1-iPSC was further supported bym Cell Reports j Vol. 2 j 896–909 j June 3, 2014 j ª2014 The Authors 901
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(Figures 2E and S3D–S3F). These results support our finding
that reactivation of the inactive parental X chromosome
occurs, followed by inactivation.
Reprogramming Activates the Inactive
X Chromosome in Female Fibroblasts
We reasoned that if XCR occurs, cells with converted drug
resistance might arise from cells undergoing active reprog-
ramming. In order to test this hypothesis, we induced the
reprogramming of fLNS-6TG cells (XaHPRT XiHPRT+) and
tested the 6TG and HAT resistance during reprogramming.
At 10 days after reprogramming, we added HATor 6TG into
the reprogramming medium and continued reprogram-
ming for an additional 2 weeks. Remarkably, iPSC colonies
that were resistant to HATarose (Figure 3A), suggesting that
a reactivation of the inactive X chromosome occurs during
reprogramming. Previous studies (Mekhoubad et al., 2012;
Tchieu et al., 2010) reported that the X chromosome status
is maintained during reprogramming. The Plath group
used a lentiviral vector system that expresses four reprog-
ramming factors in one backbone (STEMCCA vector),
whereas we used a retroviral vector, which may explain
the difference in results. Thus, we tried to reprogram
the fLNS-6TG with STEMCCA vector. However, we could
isolate iPSC colonies with an opposite X chromosome state
(HAT-resistant clones; Figure 3A). Thus, the reprogram-
ming vectors do not seem to be responsible for the reactiva-
tion of the X chromosome. The relatively high expression
of reprogramming factors in our reprogramming condition
may have resulted in reactivation of the X chromosome
during reprogramming. We performed Southern blot anal-
ysis in 12 iPSC clones that were characterized for their X
chromosome status (Figure S3G). No clones showed the
same provirus integration patterns. A total of >30 provirus
integrations and eight integrations of OCT4 or SOX2 were
found in each clone (Figure S3G). No previous studies have
directly addressed the relationship between the X chromo-
some status of female iPSCs and the total number of provi-
rus integrations. However, the female iPSC clones derived
from three independent individuals via the reprogram-
ming protocol of the Eggan group showed two to six inte-
grations in OCT4 provirus and two to four integrations
in SOX2 provirus (see Figure S6 in Boulting et al., 2011),
which is fewer than observed in the iPSC clones generated
in our protocol. Thus, the reactivation of the inactive X
chromosome in iPSC clones in our protocol may be due
to the higher expression of the four factors during reprog-
ramming. Since human ESCs with two active X chromo-
somes were successfully derived under the hypoxic
condition, we tested whether the hypoxic reprogramming
condition prevents the formation of an inactive X chromo-
some (Lengner et al., 2010). As in the normoxic condition,902 Stem Cell Reports j Vol. 2 j 896–909 j June 3, 2014 j ª2014 The Authorwe obtained iPSC colonies from fLNS-6TG that showed
HAT resistance as well as 6TG resistance (Figure 3A). The
production of 6TG-resistant clones with only one active
X chromosome suggests that hypoxic reprogramming con-
ditions do not maintain the two active X chromosomes,
consistent with a previous report (Pomp et al., 2011). We
then asked whether the HAT resistance acquired by fLNS-
6TG during the reprogramming accompanied the reactiva-
tion of XCI. At 14 days of reprogramming, the GYG2 and
MAOA SNPs showed a biallelic pattern: GYG2 (C and T at
998 nt), GYG2 (A and G at 1,127 nt), and MAOA (A and
G) (Figure 3B). Overall, our data showed that reprogram-
ming reactivates the inactive X chromosome of fibroblasts.
We also took advantage of a monoallelic RTT3-iPSC-46m
clone isolated from RTT3 fibroblasts to analyze the tran-
scriptional activation of inactive X chromosome during re-
programming (Kim et al., 2011). RTT3 fibroblasts originate
from a female RTT patient who had a nucleotide deletion
(705 delG) in the middle of MECP2. This deletion causes a
frameshift in the codon and ultimately produces C-termi-
nal deletion MECP2 protein. The RTT3-iPSC-46m clone
is monoallelic and expresses only mutant MECP2 allele
(Figure 3F). Thus, the antibody against the C terminus of
MECP2 does not recognize it. We differentiated RTT3-
iPSC-46m iPSCs into fibroblasts to produce dfRTT3-46m
cells. The inactive X chromosome status was maintained
in dfRTT3-46m, and an antibody for C-terminal MECP2
didnot detectmutantMECP2.We initiated reprogramming
of dfRTT3-46m and analyzed the production of MECP2 at
days 14 and 21 by performing western blotting and immu-
nostaining. Remarkably, we found that cells undergoing
reprogramming produced wild-type MECP2 from days 14
and 21 (Figures 3C–3E). These results provide definitive ev-
idence that the XCR that resulted in loss of H3K27m3 foci
and low expression of XIST and RNF12 upon reprogram-
ming had become a state in which transcription was active.
Nascent iPSCsContain the InactivatedXChromosome
If the inactive X chromosome becomes activated during
reprogramming, how are the monoallelic iPSCs that have
one active X chromosome produced? In order to answer
this question, we performed an extensive analysis of
change in the X chromosome state in established iPSC
clones. Our previous analysis of cellular marks during pro-
gramming found that the silencing of retrovirus-mediated
GFP expression occurs when cells become fully reprog-
rammed and make faithful iPSCs (Chan et al., 2009; Kim
et al., 2012). At 28 days after reprogramming, when iPSC
colonies arose, we examined X chromosome status by
staining cells for H3K27me3. Unexpectedly, we found
that all of the nascent iPSC colonies with no GFP expres-
sion displayed H3K27me3 foci, suggesting that all of
them had an inactive X chromosome (Figure 4A). In orders
Figure 3. XCR during Active Reprogramming
(A) Crystal violet staining of a reprogrammed whole cell in a six-well plate. 6TG-resistant fLNS-6TG (XaHPRTXiHPRT+) cells were induced for
reprogramming in a normoxic or hypoxic condition using pMIG retroviral vector, or in a normoxic condition using STEMCCA lentiviral
vector. After 10 days, reprogramming was continued in medium with HAT or 6TG for 2 weeks. Seven days after HAT was withdrawn, the plate
was stained for crystal violet. In all three conditions, iPSCs with resistance to HAT were formed.
(B) Allelic-specific sequencing of GYG2 and MAOA in cells under 14 days of reprogramming.
(C) Immunostaining of wild-type (WT) MECP2 in dfRTT3-46m cells undergoing reprogramming at the indicated times with antibody
recognizing the C terminus of MECP2 (red) and DAPI (blue). White arrows indicate WT of MECP2 and yellow arrows indicate the mutant type
of MECP2. Scale bar, 20 mm.
(D) Quantification of WT MECP2+ cells in dfRTT3-46m cells undergoing reprogramming in (C). Four randomly chosen fields were used to
count the number of MECP2+ cells and to calculate the percentage. Error bars represent mean ± SEM.
(E) Protein expression of WT of MECP2 in dfRTT3-46m fibroblasts undergoing reprogramming. At 10 and 21 days after reprogramming,
whole-cell extracts were immunoblotted for MECP2 antibody recognizing the C terminus of MECP2.
(F) Representative SNP of MECP2 in secondary iPSCs.
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Human X Chromosome State Change in Reprogrammingto examine the XIST and RNF12 expression in GFP
colonies, we performed quantitative PCR in cells isolated
using surface markers and GFP expression. Consistent
with the change in H3K27me3 staining, the expression of
XIST and RNF12 together with pluripotency markers was
highly upregulated in the SSEA4+/TRA160+/GFP popula-
tion isolated at day 28, whereas cells that showed GFP and
thus had high expression of reprogramming factors
showed low expression of RNF12 and XIST (Figures 1G
and S2E). Thus, it seems that before cells become fully re-
programmed, the X chromosome is in an active state,
perhaps due to the suppression of XIST and RNF12. The
silencing of ectopic reprogramming factors activates XIST
and RNF12, and the X chromosome becomes inactivated
and marked by precipitous H3K27me3 foci formation in
nascent iPSC clones (Shin et al., 2010). These results sug-
gest that the active X chromosome during reprogramming
is transient and the X chromosome becomes inactivated
following completion of reprogramming, leading to the
formation of a monoallelic X chromosome state in newly
formed nascent iPSC clones.
XCR in iPSCs
Although the initial female iPSC colonies displayed the
marker for an inactive X chromosome in the current study
(Figure 4A), other groups and we have previously reported
the isolation of biallelic iPSCs with two active X chromo-
somes from female somatic cell reprogramming (Kim
et al., 2011; Marchetto et al., 2010; Tomoda et al., 2012).
It seems that biallelic iPSCs arise during picking and expan-
sion. In order to test this, we closely examined X chromo-
some status in iPSC clones at each passage after the initial
picking. First, the nascent iPSC clones picked from the orig-
inal reprograming plate were denoted as ‘‘passage 0.’’ We
picked ten iPSC colonies without GFP expression from aFigure 4. Formation of Class I and Class III iPSC Clones in Early P
(A) Schematic of tracing the X chromosome after reprogramming. iPSC
silenced nascent iPSC colonies display H3K27me3 foci. In order to trac
were fixed and half were used for passaging. Scale bar, 20 mm.
(B) Appearance of H3K27me3 foci-negative cells in iPSC clones duri
H3K27me3 foci-negative cells upon passaging, whereas D551-iPSCN6
(C) Percentage of iPSC clones that underwent the H3K27me3 foci-pos
H3K27me3 foci-positive Detroit 551-derived iPSC clones were picked
(D) FISH for XIST RNA in iPSCs at passage 10 to determine the X chro
(E) Representative images of H3K27me3 and OCT4 staining in 6TG-iPSC
and displays H3K27me3 foci before and after differentiation. 6TG-iPSC
differentiation. 6TG-iPSC25 is a class III iPSC, and no H3K37me3 foci e
Scale bar, 20 mm.
(F) Representative images of XIST and ATRX FISH in 6TG-iPSCs at pas
displays one XIST and one ATRX focus before and after differentiatio
differentiation. Two ATRX foci become one after differentiation. 6TG
differentiation. Scale bar, 20 mm.
Steplate of reprogrammed Detroit 551 or RTT3 fibroblasts.
During passaging, half of the colonies were picked up for
the next passage and the other half were fixed for
H3K27me3 staining (Figures 4A and S4A). We repeated
the picking and passaging up to passage 10. At each pas-
sage, we examined the H3K27me3 status in iPSC colonies.
Interestingly, four out of ten D551-iPSC colonies started to
show an area without H3K27me3 foci following passage 1
or 2 (Figures 4B, 4C, and S4B). All cells in the clones that
had begun to lose H3K27me3 foci eventually became
H3K27me3 foci- and XIST-negative. The remaining six
colonies maintained the H3K27me3 and XIST foci (Figures
4B–4D, S4C, and S4D). This gradual gaining of H3K27me3
foci-negative cells and the loss ofXIST expression were also
observed in iPSC clones from fLNS-HAT and fLNS-6TG
fibroblasts (Figures S4E and S4F). These data suggest that
either monoallelic iPSCs become biallelic iPSCs after pick-
ing and expansion or a few biallelic iPSCs exist in the col-
onies that have a growth advantage, and they become
dominant cells during picking and expansion. Our current
data cannot exclude either possibility.
The absence of H3K27me3 foci and XIST expression in
iPSCs suggests that these cells are class I iPSCs that have
two active X chromosomes. However, the continuous cul-
ture of class II iPSCs can result in a partial reactivation of
the inactive X chromosome due to an epigenetic change
of the X chromosome (so-called ‘‘erosion’’), resulting in
class III iPSCs (Mekhoubad et al., 2012). Erosion and full re-
activation can be distinguished by the formation of
H3K27me3 foci and XIST expression in cells differentiated
from iPSCs. In order to determine whether iPSC clones that
have no H3K27me3 foci orXIST are class I or class III iPSCs,
we differentiated 12 iPSC clones derived from fLNS-6TG fi-
broblasts by treating them with retinoic acid for 14 days.
The formation of H3K27me3 foci, XIST, and ATRX cloudassaging
s undergo rapid XCI upon completion of reprogramming, and all GFP-
e the X chromosome status after reprogramming, half of the colonies
ng passaging. H3K27me3 foci-positive D551-iPSCN1 iPSCs became
remained an H3K27me3 foci-positive clone. Scale bar, 20 mm.
itive to -negative transition during passaging in (B). A total of ten
and expanded to trace the change of H3K27me3 status.
mosome status. Scale bar, 20 mm.
s at passage 10 and differentiated cells. 6TG-iPSC22 is a class II iPSC
26 is a class I iPSC and shows formation of H3K27me3 foci only after
xist before or after differentiation. Arrow indicates H3K27me3 foci.
sage 10 and differentiated cells. 6TG-iPSC22 is a class II iPSC and
n. 6TG-iPSC26 is a class I iPSC and shows formation of XIST after
-iPSC25 is a class III iPSC, and no XIST foci exist before or after
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Six of 12 clones showed an X chromosome status of class II
type, having XIST and H3K27me3 foci in iPSCs and differ-
entiated cells (e.g., 6TG-iPSC22; Figures 4E and 4F). The
other six iPSC clones showed no H3K27me3 foci or XIST
cloud before differentiation, suggesting that they were
either class I or class III iPSC clones. In three clones,
H3K27me3 foci and XIST cloud arose after differentiation,
confirming that they were class I iPSC clones (e.g., 6TG-
iPSC26; Figures 4E and 4F). Meanwhile, the other three
clones did not showH3K27me3 foci orXIST cloud after dif-
ferentiation, representing the ‘‘eroded’’ state of the X chro-
mosome (6TG-iPSC25; Figure 4F). SNPs in GYG andMAOA
genes of 12 iPSCs further confirmed the allelic expression
of X chromosome genes (Table 1). Our results indicate
that either class I or class III iPSCs can arise from nascent
iPSC colonies with inactive X chromosome marks.DISCUSSION
Here, we demonstrate that the status of the X chromosome
is dynamic during human female somatic cell reprog-
ramming. Extending previous studies that examined X
chromosome status in iPSCs after completion of reprog-
ramming, we determined the change of X chromosome sta-
tus in cells at different stages of reprogramming and after
they were established as iPSC clones. We found that strong
ectopic expression of reprogramming factors markedly
suppresses XIST and RNF12, and mediates the reactivation
of the inactive X chromosome (reprogramming XCR
[rXCR] in Figure S5D). Although it is transient, the reacti-
vated X chromosome at rXCR is transcriptionally active
(Figure 3). When reprogramming was completed, the
nascent iPSC clones were shown to be composed mostly
of cells possessing the inactive X chromosome marker
H3K27me3 foci. These results suggest that the reactivated
X chromosome state in cells under active reprogramming
is transient, and the timing of inactivation of the X chro-
mosome is well correlated with the silencing of ectopic re-
programming factors (Chan et al., 2009). In murine ESCs,
the reprogramming factors Oct4 and Nanog bind to intron
1 of Xist and suppress its transcription, whereas Myc and
Klf4 bind to DXPas34 of Tsix to activate the transcription,
resulting in two active X chromosomes (Deuve and Avner,
2011). Likewise, the high expression of the reprogramming
cocktail in the current study may suppress XIST in cells
undergoing reprogramming and reactivate the inactive
X chromosome. When cells become bona fide iPSCs, the
retroviral silencing machinery becomes activated (Chan
et al., 2009; Matsui et al., 2010) and reduces the ectopic
expression of reprogramming factors and thus the suppres-
sion of XIST. Remarkably, the formation of monoallelic906 Stem Cell Reports j Vol. 2 j 896–909 j June 3, 2014 j ª2014 The AuthoriPSC clones composed of the same inactive X chromosome
indicates that out of many cells undergoing reprogram-
ming, only one cell becomes an iPSC clone and thus has
one allele of the inactive X chromosome.
Tracing of the nascent iPSC clones that were composed
mostly of H3K27me3 foci-positive cells showed that cells
with no H3K27me3 markers became dominant in some
clones during very early passages. There are two possible
explanations for this: either H3K27me3 foci-positive class
II iPSCs become H3K27me3 foci-negative class I or class
III cells, or some existing H3K27me3 foci-negative iPSCs
that have a growth advantage become dominant during
passaging. In a detailed analysis of the X chromosome
state, we found that class I iPSCswith two active X chromo-
somes, as well as class III iPSCs with one active and one
eroded X chromosome, arose in early passages (Figure 4F).
Although a previous report by the Eggan lab suggested
that the long-term culture of iPSCs results in X chromo-
some erosion (Mekhoubad et al., 2012), our data show
that X chromosome erosion occurs even in very early pas-
sages. Currently, it is unknownhow class I iPSC clones arise
from class II nascent iPSCs. Perhaps the neighboring non-
reprogrammed cells suppress the XCR in nascent iPSCs
via paracrine factors (Bendall et al., 2007; Xu et al., 2005),
and when the iPSCs are picked and placed in a new culture
plate without the influence of these factors, XCR may
occur. During development, the X chromosome shows
dynamic changes in state. The X chromosome becomes
activated in the ICM inmouse (Lessing et al., 2013). Preim-
plantation human embryos also show twoX chromosomes
in the pre-XCI state (Lengner et al., 2010; Okamoto et al.,
2011). Following random inactivation in the epiblast stage,
the X chromosome becomes reactivated in PGC develop-
ment (Sugimoto and Abe, 2007). The reactivation of the
X chromosome during reprogramming shown by our re-
sults suggests that reprogramming mimics either preim-
plantation embryo development or PGC formation where
XCR occurs.
iPSC clones with different X chromosome status have
been isolated by several groups (Ananiev et al., 2011;
Cheung et al., 2011; Pomp et al., 2011; Tchieu et al.,
2010). Some groups isolated iPSCs with one active X chro-
mosome and others isolated two active X chromosomes.
The medium used for reprogramming does not seem to
be responsible for the different results, because all of these
groups used a standard medium composed of knockout
serum replacement and basic fibroblast growth factor
(Amit et al., 2000). The reprogramming methods used by
each group may not result in iPSCs with different X chro-
mosome status. The Plath group used retro- or lentiviral
polycistronic vectors that express four reprogramming
factors in one backbone (Tchieu et al., 2010). The Ellis,
Colman, Chang, and Eggan groups all used retrovirus fors
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2012; Pomp et al., 2011). We used a lentiviral STEMCCA
vector that was used by the Plath group (Figure 3A).
Although the Plath group did not report XCR, we found
that the STEMCCA vector gives rise to iPSCs with XCR.
Thus, the vectors used for reprogramming do not unambig-
uously explain the differential X chromosome status in
iPSCs. Although isogenic iPSC clones can be isolated
from reprogramming of female fibroblasts, some of the
above-cited papers reported that monoallelic iPSC clones
with only one inactive X chromosome, but no other
X chromosomes, were isolated from some lines (Cheung
et al., 2011; Pomp et al., 2011), whereas we readily isolated
iPSC clones with two different X chromosome states.
OCT4, SOX2, MYC, and KLF4 were shown to play critical
roles in reactivation of the inactive X chromosome (Deuve
and Avner, 2011; Lessing et al., 2013; Navarro et al., 2010).
Differences in viral infectivity or the amount of virus added
may have influenced the expression of reprogramming fac-
tors and thus X chromosome state during reprogramming.
Indeed, the analysis of provirus integration in our iPSC
clones showed many more integrations compared with
those derived by the Eggan group (Figure S3G; Boulting
et al., 2011; Mekhoubad et al., 2012). Another possibility
is the difference in the fibroblast line of resistance to re-
programming, for which the epigenetic barriers may pre-
vent the XCR during reprogramming. The different feeder
conditions used cannot be ruled out as a possible cause,
since the Yamanaka group showed that feeder cells that
produce high LIF support the derivation of iPSCs with
two active X chromosomes (Tomoda et al., 2012). However,
the feeder we used does not express high LIF and is less
likely to be a cause of X reactivation.
Considering the importance of female iPSCs for disease
modeling and future cellular therapeutics, it is critical to
acquire concrete information about the X chromosome
state in given iPSC clones. X-linked monogenic diseases
show different penetrance inmales and females depending
on the recessive or dominant role of the mutated genes
(Dobyns et al., 2004). Maintaining one of the inactive X
chromosomes in an inactive state in female iPSCs will be
essential, especially for studying diseases such asDuchenne
muscular dystrophy, hemophilia A and B, and a-thalas-
semia, where there is a low penetrance in the female and
the mutated genes are recessive (Dobyns et al., 2004).
When applying the in vitro differentiated derivatives of
female iPSCs as therapeutics, it will be crucial to maintain
the XCI because epigenetically unstableXIST-negative cells
express oncogenes (Anguera et al., 2012) and could lead to
tumor, as reported in XIST-depleted leukemia in a murine
model (Yildirim et al., 2013). Thus, our current study
delineating the X chromosome status of cells during and
after reprogramming provides an important foundationStefor the use of female iPSCs in disease modeling and cell
therapeutics.EXPERIMENTAL PROCEDURES
Cell Culture and Reprogramming
Normal primaryfibroblastsDetroit 551,WI38, and IMR90werepur-
chased from theAmericanTypeCultureCollection (CCL-110,CCL-
75, and CCL-186, respectively). Fibroblast cell lines from patients
with RTT (RTT3, GM07982; RTT4, GM11270; and RTT5,
GM17567) and fLNS-HPRT+/ (GM02226) were obtained from the
Coriell Institute for Medical Research. iPSCs were reprogrammed
andmaintained as described in Supplemental Experimental Proce-
dures. dfD551-K1, dfRTT1-13w, dfRTT3-46m, dfRTT4-24w, and
dfRTT5-34m were generated by differentiating monoallelic D551-
iPSCK1, RTT1-iPSC-13w, RTT3-iPSC-46m, RTT4-iPSC-24w, and
RTT5-iPSC-34m iPSC lines, respectively, into fibroblast-like cells.
To induce differentiation, iPSCs were dissociated using Accutase
(Millipore) with the addition of rock inhibitor (Y27632; Sigma),
and cells were plated on gelatin-coated plates. Cells were cultured
in Dulbecco’s modified Eagle’s medium with 15% fetal bovine
serum and nonessential amino acid over 4 weeks, and used for
reprogramming.HAT and 6TG Selections
In order to isolate two homogeneous subpopulations of fLNS-HAT
(XaHPRT+XiHPRT) and fLNS-6TG (XaHPRTXiHPRT+) from HPRT+/
fibroblasts, cells were incubated with culture medium containing
either 60 mM of 6TG or 13 HAT for 14 days. Each selected subpop-
ulation was used for reprogramming to generate iPSCs. In order to
determine the allelic specificity of HPRT in iPSC clones derived
from fLNS-HAT and fLNS-6TG subpopulations, iPSCs were treated
with collagenase and plated as small colony clumps in six-well
plates coated with mouse embryonic fibroblasts. Three days after
plating, cells were cultured with human ESC culture medium con-
taining HAT or 6TG for 10 days. Cells were fixed with 4% formal-
dehyde/PBS and stained with crystal violet.Gene-Expression and SNP Analyses
RNA was isolated from iPSCs using an RNeasy minikit (QIAGEN),
and 1 mg of RNA was used for reverse transcription with iScript
(BioRad) according to the manufacturer’s protocol. Gene-expres-
sion and SNP analyses were performed as described in Supple-
mental Experimental Procedures.Immunostaining
iPSCs or cells undergoing reprogramming were fixed for 10 min at
room temperature with 4% paraformaldehyde in PBS and stained
as described in Supplemental Experimental Procedures.FISH for XIST/ATRX, Western Blot, and Southern Blot
RNA FISH was carried out as described previously (Tchieu et al.,
2010). Detailed methods for FISH, western blot, and Southern
blot are described in Supplemental Experimental Procedures.m Cell Reports j Vol. 2 j 896–909 j June 3, 2014 j ª2014 The Authors 907
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